Mammary tumors frequently developed in mice of some of the strains receiving estrogens and in several cases they were removed under general anesthesia.
Atypical uterine conditions, particularly those classified as glandular cystic hyperplasia and fibroids, have been considered to follow altered ovarian function or endocrine imbalance.' Direct experiments have demonstrated that these conditions could be more or less completely reproduced in one or more species of laboratory animals if estrogens were administered over prolonged periods. 2 Malignant neoplasms have not been so generally observed, however. Lesions, histologically malignant, precancerous, or cancer-like were reported by several investigators as appearing in mice which had received estrogens3`7 or estrogens and carcinogens simultaneously. 8 Most of these lesions were small. Though showing varying degrees of invasiveness, metastases were not observed. Because of their usual small size they were not diagnosed during life to determine the possibility of regression following the cessation of estrogenic injections. A transplantable, metastasizing carcinoma, presumably of cervical origin, occurred in one mouse receiving estrogen. 9 Eighteen other mic-were mentioned as showing probable earlier stages of the same malignant process or "precancerous" changes. The above observations indicated that estrogens played a r8le in cervical malignancies. These lesions were apparently independent of known genetic factors.7
Materias and Methods Female mice from eight different inbred strains were used in the present study. These strains had been maintained for many generations of close inbreeding. With regard to the incidence of development of mammary tumors marked variations existed between the different strains. These strains (C3H, A, CBA, C12I, F, C57, N, and JK) were generously supplied from the colony of Dr. L. C. Strong.
Several different estrogenic chemicals* have been used, estradiol benzoate, equilin, equilin benzoate, equilenin benzoate, estradiol dipropionate, and stilbestrol. Progesterone and testosterone propionate were other sex hormones used. All of these substances were dissolved in sesame oil and injected into the dorsal tissues subcutaneously. The concentrations of the hormones were usually so arranged that 0.05 cc. was administered per injection. Injections were usually made at weekly intervals, though in some experiments at shorter or longer intervals.
Control mice were either untreated, given weekly injections of sesame oil or sesame oil containing cholesterol or cholesterol benzoate. All mice were maintained on Purina Fox Chow.
Mammary tumors frequently developed in mice of some of the strains receiving estrogens and in several cases they were removed under general anesthesia.
TI he uterus, cervix, and vagina were removed intact at autopsy and fixed in Bouin's fluid or 10 per cent formalin. The lower portion of the uterine horns, cervix, and upper vagina were sectioned serially, and 2 of every 12 sections were mounted and stained. One area of each uterine horn, usually from the central portion, was also sectioned. Test sections through the cervices and the vaginas were examined in many of the controls.
Observations were made on the size and gross appearance of the genital tissues at the tinrle of autopsy. All of the mice were observed daily during the course of the experiment and carefully examined once or twice each week. The mice were usually killed when mammary or lymphoid tumors appeared or when their general condition did not warrant their continuance. Cervical or upper vaginal tumors were diagnosed prior to autopsy in only three mice. The smaller epithelial tumors or invasions of the genital tissues in this region were only apparent after microscopic study.
Diagrams of the cervix, vaginal fornices, and the proximal portions of the uterine horns were made and the location and extent of the different epithelial lesions, to be described later, were plotted (Figs. 1 and 2). To facilitate description the lesions were classified in four groups or stages. Stage average survival time. Of the 100 mice treated, the genital tissues of 76 were sectioned and studied microscopically. The other 24 mice were autopsied, but post-mortem autolysis prevented adequate histological examination. The uterine cervices or vaginal fornices of 10 of the 76 mice adequately studied showed variable amounts of epithelial invasion. These 10 mice survived for an average of 339 days following the first injection, or 75 days more than the average of all autopsied mice. One of these lesions was a transplanted, metastasizing tumor previously described,9 which arose in a mouse killed at 364 days of age. This lesion extended through the entire cervix, the greater part of the vaginal wall, the rectum and adjacent pelvic tissues, and to the lumbar lymph nodes. The tumor was composed of invading cords of cells. It grew rapidly following transplantation to both males and females which were not treated with estrogens, and was carried for 3 transplant-generations.
The second tumor considered malignant (stage 4) in our series was much smaller, involving one-half of the cervix and the immediately adjacent posterior vaginal wall just below the posterior lip of the cervix. This lesion was composed in part of cysts lined by stratified cells and in part of cords of cells which had completely penetrated the cervical wall (Fig. 3) . These cell cords presented involved the greater part of one-half of the cervix and apparently arose either from the wall of the cervical canal, the external os, or the outer cervical wall. They consisted of cords of epithelial cells, the larger cords of which were filled with cellular debris (Figs. 1,  4 , and 10).
Six lesions of stages 2 and 1 were observed in the C3H-strain mice receiving estrogens. Those of stage 2 showed a slightly greater invasive tendency than did those of stage 1 (Fig. 5) . The points of origin of these 6 epithelial irregularities were again the wall of the cervical canal, the external os, or the outer cervical wall. The lesions were usually found in mice treated for from 300 to 400 days (Tables 2 and 3 ). The upper vagina and cervix of the mice tended to vary in size and microscopic structure depending upon the dose and the duration of treatment with estrogens. The mice receiving the larger doses usually had large cervices and thick vaginal walls (Fig. 6) . Upon gross observation they were regular in shape, even in those mice showing the smaller lesions, fibrous or hard, and whitish in color. Histologically, they showed an increase in fibromuscular tissue (Fig. 7) . Frequently this tissue was extremely loose and edematous and in some cases resembled mucoid tissue (Fig. 8) . In the mice receiving the larger doses, the cervical canal was usually small (Fig. 7) and epithelium of a low stratified squamous type lay over a thickened, regular, and somewhat hyalin basement membrane (Fig. 9 ). An accumulation of round cells lay beneath the basement membrane in some places (Fig. 9) or throughout in many of these mice. Occasionally, a hyalin-like transformation appeared in the stroma of the cervices of such intensively treated mice, particularly in the upper portion, possibly progressing from the uterus.
To a certain extent similar changes occurred in the vagina. The mucosa usually was much less folded than in untreated or in estrogen-androgen treated animals giving the epithelium a more regular appearance (Fig. 9) . The epithelium on the outer cervical wall was usually of the low stratified type,-very rarely cornified in contrast to the more frequently cornified layer on the opposing vaginal wall. Again, the basement membrane was thickened and hyalin-like in many instances, and round cells and at times leukocytes had accumulated in the mucosa. The greatest vaginal cornification was found in the mice treated for the shortest intervals, or in some of the mice receiving the monthly injections.
The cervices and vaginas differed strikingly from those of old mice which became extremely atrophic and also from those of mice showing a marked hyperplasia and hyperemia within a few days after the onset of injections. Marked hyperplasia and hyperemia were not observed in the chronically treated animals.
Malignant changes were not observed in the uterine horns of any of the mice. Two mice showed tumorous lesions, one a possible granuloma or fibroma in a uterine horn involved in a pyometra and one a subserosal accumulation of large unidentified cells.
The condition of the uterus depended greatly on the duration and intensity of treatment and the age at which the injections were started. Pyometra developed infrequently in mice of the C3H strain. Complete metaplasia occurred only in animals in which the injections were started at a very early age (Fig. I1) . The stroma showed a slight hyalin transformation and some fibrosis. Few or no glands were present, and the uteri were very small (Fig. 11) .
Cystic uteri were infrequently found in these mice and even when so classified showed no pronounced cystic condition. A hyalin degeneration of the stroma occurred with great frequency and tended to progress with the duration of the treatment (Fig. 12) . The hyalin change tended to follow a rather characteristic pattern, appearing first as two areas on opposite sides of the mesometrium 219, and progressing toward the antimesometrial endometrium on each side, apparently replacing some of the glands. A more cellular layer infiltrated with round cells and occasionally containing macrophages usually separated the basement membrane from the hyalinized areas (Fig. 12) . The entire mucosa appeared quite avascular -in such cases. Rarely did the hyalin change tend to encroach upon the muscularis. The stromal hyalinization persisted for several months after the injections of estrogen were stopped in 2 instances.
The uterine epithelium was of the usual columnar or pseudostratified columnar type (Fig. 11) . The number of cells in mitosis was never striking, except in some of the animals receiving the inter- (Table 4) .
The experiments were started in mice ranging in age from 2 to 63 days and were continued until tumors developed or until death occurred from other causes. The genital tissues of 26 of the animals were sectioned and studied microscopically. Ten of the 26 mice showed epithelial lesions, rated stages 1 to 3 (see Tables 4 and 5) , of the cervix, vaginal fornices, or utero-cervical junctions. Two areas of epithelial irregularity were observed in each of 3 mice and a single area in each of the other 7 animals. Mice of the CBA strain tolerated the injections of estrogen quite well. The average survival time following the start of the experiments was 319 days. This was appreciably longer than in mice of the C3H strain and was in part attributable to the later appearance of mammary tumors in the CBA mice. The average survival time of mice of the CBA strain showing cervical lesions was 442 days, or over 100 days more than that of mice of the same strain showing no lesions of the cervical epithelium (Table 5) , and over 100 days longer than that of the mice of the C3H strain showing epithelial invasions or cervical carcinomas.
Five mice were first given estrogens at from 2 to 9 days of age and survived for from 309 to 490 days, all dying with either mediastinal sarcomas or mammary adenocarcinomas. One of these mice showed 2 small invading epithelial growths. The uterine epithelium of 2 of these mice had undergone complete metaplasia, becoming stratified squamous. The experiments were started at from 31 to 63 days of age in the other 30 mice and complete uterine metaplasia was observed in only one instance.
The uterine cervical lesions for the most part were comparable to those in the C3H strain. In all except 3 mice the lower cervical canal was involved. In one of these mice a very small lesion (stage 1) occurred on the cervical wall of one of the lateral fornices; in the second a large tumor (stage 3) was present in the upper cervical canal and involved the lower uterine horns; and, in the third a few small cords of epithelial cells invaded the mucosa (stage 1) at the utero-cervical junction. A small adenocarcinomatous lesion was present in another mouse which also showed a squamous-cell invasion of the epithelium of the cervical canal and external os.
Pyometra developed in 11 animals of this strain. The inflammatory process was usually localized in one horn or part of one horn and resulted in a large abscess. A slight leukocytic infiltration was present occasionally throughout the rest of the uterus. In nearly all animals some leukocytic invasion occurred in the lower part of the uterine horns just above the cervix. The points of transition between the stratified cervical epithelium and columnar uterine epithelium were extremely irregular. In this region localized areas of glandular tissue interspersed with areas of dense hyalin tissue usually replaced the normal mucosa and frequently encroached upon the myometrium. The extreme reaction at the utero-cervical junction was quite characteristic of this strain. The extent of uterine hyalinization tended to increase with the duration of treatment (Fig. 14) .
Thirty female mice of the C12I strain were given estradiol benzoate at 3 different levels, 16.6y or 8.3y weekly or 16.6y every third week (Table 6 ). Nineteen of these mice were autopsied and the genital tissues were sectioned for microscopic study. The other 11 mice were examined after death and no tissues were saved. Of 22 mice given 16.6y of estradiol benzoate weekly, 14 were autopsied after from 78 to 217 days of treatment-average 147 days. Epithelial irregularities of variable extents were found in 5 of these mice (Table 7) after treatment of from 147 to 203 days. The most extensive lesions appeared in a mouse treated for a period of 198 days. All of these mice, with the exception of the one showing the stage 3 lesion, had pyometra involving one or both horns of the uterus. In the latter mouse polymorphonuclear cells were found in the uterine lumen and in the walls, but the extent of infiltration was insufficient to demonstrate an active inflammatory condition.
Two areas of epithelial irregularity were observed in the cervices of each of 2 mice of this strain. In both cases one lesion occurred in the cervical canal and another at the lower portion of one of the (Fig. 15) . The cervical epithelium was absent in several places and the exposed surface of the epithelial invasion was heavily infiltrated with leukocytes. The cervices of all of the mice receiving the large amounts of estrogen were large, usually white, and fibrous. The cervical canals were usually very small, occasionally almost closed, the low stratified squamous epithelium of the opposing walls being fused throughout the greater portion.
The uterine horns of mice of this strain presented no evidence of neoplastic changes. Cystic hyperplasia predominated in the mice receiving the smallest amount of estrogen. The uteri of mice receiving the 2 larger doses presented pictures of pyometra and in 4 instances metaplasia. In some presenting a slight cystic condition, local hyalin areas were scattered throughout the endometrium. Twenty-seven female mice of the A strain were given either SOy of estrone benzoate weekly or 16 .6y of estradiol benzoate weekly for periods up to 355 days. Injections were started in 19 mice from 1 to 9 days and in the other mice at 25 to 40 days of age. The uterine horns were removed from 3 mice prior to the administration of estrogen.
The mice receiving estrogens starting when very young responded in a fairly constant manner. The uterine cervices were all tremendously enlarged, firm, and whitish in color (Fig. 6) . The uterine horns were small, 1 to 1.5 mm. in diameter, white, and firm. The cervix, histologically, showed hypertrophy of the fibromuscular tissue and an edematous or mucoid transformation of the stroma (Fig. 8) . The epithelium was usually of the low stratified type. The uterine epithelium of many of these animals was also stratified squamous, and comparatively few glandular structures were present. The uterine stroma was either fibrous or diffusely hyalinized. The myometrium was poorly developed. Even the mice which received estrogens starting at 25 days of age had small uteri. The epithelium was stratified in only one instance. Pyometra was observed in only 3 mice.
The vaginal and cervical epithelium was of the stratified squamous type in all animals. Comparatively little cornification occurred in animals treated for 150 days or more. The basement membrane was distinct and quite regular in all except one animal.
Of the 3 animals from which both uterine horns were removed down to the point of bifurcation 2 showed at autopsy, 198 and 194 days after the first weekly injection of 16.6y of estradiol benzoate, invasive epithelial lesions (stages 2 and 4). A lesion considered to be a carcinoma was found in one of these mice. The tumor extended from the utero-cervical junction about one-third of the way down the vagina, involving and enlarging one-half of the cervix and the upper vaginal wall. The loose connective tissues surrounding the vagina were also involved, as was the dorsal wall of the urethra. 
vaginas. The uteri were either very large and cystic or involved in a pyometra. The average survival time was only 181 days, as females of this strain have tolerated injections of estrogen poorly. Twenty-two female mice of the N strain were given subcutaneously estrogens in oily solution for variable periods. These mice tolerated estrogen in large amounts (SOy weekly) very poorly, 9 mice dying after an average period of treatment of 82 days. Most of these mice died with pyometra. Four hysterectomized mice receiving comparable treatment survived nearly four times as long (233 days). The uteri were transformed to large abscess-like masses and were involved in multiple adhesions to the peritoneum. The uteri of the 9 mice receiving the smaller amounts of estrogen (1 6 Epithelial irregularities were not observed in the vaginas or cervices of any of these mice. Estradiol benzoate was administered at the rate of 50y and 1 00y weekly to 4 female mice of the F strain. All of these mice developed pyometra and died after a period of from 62 to 87 days. In one mouse the uterine epithelium was entirely removed by the inflammatory mass. In the other 3 mice metaplasia was complete or irregular throughout the uterine horns. The cervices were greatly enlarged by a proliferation of fibromuscular elements and edema. The vaginas were lined by thickly stratified squamous epithelium but showed little cornification. The walls of the cervical canals were thickly stratified and the outer layers were slightly cornified.
Estradiol benzoate and testosterone propionate have been administered simultaneously to mice of several strains, but thus far sufficient numbers have survived over long periods in only two strains (C3H and C12I) to warrant discussion. Eight female mice of the C3H strain have been autopsied after periods of treatment of from 161 to 431 days. Of this number the tissues of 6 have been adequately studied. One mouse had a large tumor extending from the distended vagina. At autopsy, tissue from the tumor was transplanted into 4 other mice of the same strain. One of the 4 mice developed a tumor at the site of transplantation but the tissue was misplaced in the process of cutting and was never observed microscopically. The other 3 mice have not shown any growth of the graft. A tumor was detected at autopsy in a second mouse but was not transplanted. These mice are listed individually in Table 9 .
All of the mice receiving weekly, in 2 injections, 2.5 mgm. of testosterone propionate and 16.6y of estradiol benzoate showed striking lesions, two of which were mentioned above. The other 2 mice showed lesions of stages 1 and 3.
The genital tracts of the mice so treated differ appreciably from those of animals receiving estrogens. The cervices and upper vaginas were less enlarged (except in the 2 showing large tumors).
The uterine horns were either very small, or they were soft, pliable and slightly enlarged. Microscopically, the uteri were lined by a low columnar epithelium. The number of glands was apparently decreased. The stroma was fibrous, coarse collagenous fibers replacing the cellular and finely fibrillar structure of the normal uterus. The muscularis was usually quite well developed, as was the vascular intermuscular layer. The cervical canal was very large (Fig. 2) . The low, stratified, pseudo-stratified, or even tall columnar epithelium lining the canal was thrown into folds making the basement membrane extremely irregular (Fig. 16) . Evidences of abnormal epithelial invasion occurred in the cervical canal of only 2 mice (3 and 7, Table 9 ). The folding of the epithelium increased toward the external os.
The vaginal walls of the cervices were lined by a low stratified epithelium showing an increased tendency to be thrown into folds, but usually more regular than the opposite vaginal walls (Fig. 17) . Extreme folding occurred in the vaginal epithelium. The lesions observed in the 4 mice all occurred from such an epithelium.
The cervical stroma was composed of a moderately cellular tissue. The basement membranes were delicate and not thickened as in many of the estrogen-treated mice. Except in the areas of infiltration the stroma contained few round cells or leukocytes.
The lesions of all of the mice receiving the larger amounts of testosterone were characteristically different from those of mice receiving estrogens alone (Figs. 18-21) . The invading cells, arranged in alveolar structures or cords, showed litde stratification and no cornification. The peripheral portions of the two larger tumors were composed of more solid cords (Figs. 19 and 20) . The larger ones, though not extending into the remote pelvic tissues, had completely invaded the vaginal wall, as had the smaller lesion ofstage3 (Fig. 18) .
Four mice of the C12I strain also received similar treatment. The response of the genital tissues was much the same as was that of the C3H strain receiving similar treatment. Epithelial invasions were observed in but one mouse. This animal had received 33.3y of estradiol benzoate and 1.25 mgm. of testosterone propionate weekly and survived for 431 days. Four separate epithelial invasions were present involving the cervical canal, vaginal fornices, and vaginal walls (stage 3). The structure of the invasive cords in this mouse closely resembled that of the mice receiving estrogens. The large folded and open cervical canals of these mice contrasted strikingly with the condition observed in animals of the same strain receiving estrogens alone. It is also interesting that these mice lived on the average of about 120 days longer than did the mice receiving estrogens alone, even though some of the latter groups received much smaller amounts of estrogens.
Estradiol benzoate and progesterone were injected into 2 female mice of the C3H strain and 4 mice of the N strain. The 4 mice of the N strain received 6.66y of estradiol and 800y of progesterone weekly for from 67 to 176 days. Three of the mice died with pyometra. The uterine, cervical, and vaginal changes were not sufficiently different from those of the estrogen-androgen treated mice to merit extensive description. The cervical canals tended to be larger and the epithelium more extensively folded in the vaginal and cervical walls. Epithelial invasions were not observed.
The 2 mice of the C3H strain received 16.6y of estradiol benzoate and 200y of progesterone weekly for 123 and 273 days. An extensive epithelial invasion involving the entire cervix occurred in the mouse treated for the longer period. This lesion was rated as stage 3. Histologically, it was quite similar to the epithelial invasions which occurred in the estrogen-treated animals. The vaginal and uterine picture was quite like that observed in the mice receiving estrogen and testosterone simultaneously. The vaginal and cervical epithelium was extensively folded. Hyalinization of the uterine stroma was not observed. Controls The genital tissues of 31 female mice of the C3H strain were examined following the injection of sesame oil, cholesterol, or cholesterol benzoate in solution in sesame oil. These mice survived for periods of from 152 to 675 days, averaging 382 days. In addition, observations were made on 17 untreated mice of the C3H strain from 148 to 492 days of age, 24 mice of the CBA strain from 150 to 723 days of age, 9 A-strain mice from 133 to 356 days of age, 13 N-strain mice from 152 to 427 days old, and 10 JK-strain mice from 107 to 483 days of age. A total of 104 mice, untreated or treated with non-estrogenic materials, was thus studied. Serial sections of the uterus, cervix, and upper vagina were not made in many cases, but test sections of the tissues were cut. The gross appearance of the uteri and cervices varied greatly as might be expected, from small atrophic organs to fully developed hyperplastic structures. The variability was greatest in the tissues in the older animals. In no instance, however, were lesions found that might be considered comparable to those described in the mice receiving estrogens or estrogens and testosterone. As described by others, the vaginas and cervices of the older animals tended to show increased folding which added to the irregularity of the basement membrane as well as to the increase in papilla. There was, however, no indication in our material that epithelial invasion had occurred as in the treated mice. Discussion
Several factors of significance in relation to the development in the uterine cervix and upper vagina of carcinomas and cancer-like lesions which appear to be early stages of a malignant change arise from the investigations undertaken. The role of estrogens in mammary carcinogenesis in mice has been complicated by the co-existence of intrinsic factors apparently transferred from parents or parent to offspring. This complicating factor does not exist, so far as is known, for tumors of the uterus or cervix. Uterine tumors, particularly epithelial tumors, rarely develop in mice as found by observations in other laboratories." The absence of invasive lesions in the 104 untreated or non-estrogen treated mice in this study also indicated their rarity. As in the mammary glands, estrogens induce profound proliferative changes in the uterus and vagina. With continuous treatment the hyperplastic processes recede even though treatment is continued, with certain exceptions. In the mammary glands, localized areas undergo proliferation resulting in hyperplastic nodules of mammary tissue. These nodules may resemble small adenomas which appear in some cases to undergo malignant changes,'2 possibly even in the absence of further estrogenic stimulation. Likewise, in the more or less static cervices of mice receiving extensive estrogenic treatment one or more areas appear to undergo certain changes leading to an epithelial invasion of the deeper tissues. Though the smaller epithelial lesions present little evidence, in some ways, of malignancy, they form a series of intermediate stages of increasing extent, finally culminating in carcinoma. In mice that have been selected for many generations for a tendency to develop mammary tumors, only comparatively brief estrogenic treatment is necessary before mammary adenocarcinomas develop in males. Longer periods of treatment are required in strains showing a lower incidence of mammary cancer.'3 In certain strains of mice, mammary tumors were not observed following the injection of estrogens.5 Strangely, mice from the strains more resistant to the spontaneous mammary tumors tolerated estrogenic stimulation least satisfactorily (see Table 1, strains C57, N, JK, F). They survived for periods too brief for mice of the highly susceptible mammary tumor C3H strain to develop breast tumors.
The cervical epithelial invasions and tumors appeared at a later average age than did the mammary tumors and at a lower incidence. For instance, one mouse with a malignant transplantable cervical tumor had had its life prolonged by twice removing mammary tumors. In the C12I strain the cervical lesions tended to appear comparatively early, a point that might be of interest in further investigation. However, the absence of lesions in mice of the other strains, N, C57, JK, and F, cannot be taken as indicating the lack of response to estrogens, as their survival was of approximately equal duration or was shorter than that of the C12I mice. Few mice from these strains survived as long as any of the animals from the C3H or CBA strains which developed invasive lesions of the cervix.
Because of the small number of animals in certain groups and the absence of one or more levels of treatment in several strains, an indication of the most effective level of treatment cannot yet be stated. Likewise, insufficient data are available to determine whether interrupted doses or continuous treatment is most satisfactory for the experimental development of cervical or uterine lesions of a cancerous nature. From the data available the duration of the period of treatment rather than the amount seems to be of greater significance.
The extremely high incidence of cervical or upper vaginal tumors and epithelial lesions in mice receiving one level of estrogentestosterone treatment might be of great interest. Though the data are limited, it appears that other levels with larger amounts of estrogen in relation to the amount of testosterone may give different results. Unlike the tendency for localization of the early lesions apparent in the estrogen-treated mice at one or two areas, the lesions in the animals receiving the two hormones tend to be more diffuse or generalized. The atrophic changes in the stroma are largely inhibited even in those mice which received amounts of the two hormones that did not give rise to tumors in the experiments reported here.
The influence of testosterone on inhibiting spontaneous mammary tumors in female mice has been reported.14 It will not completely inhibit breast tumors in mice receiving estrogens (see Table 9 ), as was also observed by Lacassagne."5 It is interesting that in the estrogen-androgen experiment reported here the number of cervical and vaginal tumors equaled the number of mammary tumors and that in two other mice epithelial lesions occurred in the upper vagina and cervix which were graded 1 and 3. It appears that hormone balance may be significant in the establishment of malignant processes and that these balances may differ for different genital tissues or organs, in this instance the mammary glands and uterine cervix or upper vagina.
At the present time, it does not seem desirable to state that such experiments as those reported here demonstrate more than a probability that the above hormones play a significant role in the etiology of spontaneous cancer of the organs involved in those species in which they occur. The absence of such lesions in untreated animals and their presence in the treated animals, however, certainly demonstrate that directly, indirectly, or in combination with other factors they play a significant r81e in experimental carcinogenesis. As far as is known the malignancies of the uterine cervix or upper vagina have not been obtained in experimental conditions following the subcutaneous (systemic) application of any other chemical agent.
Vaginal or cervical carcinomas have, however, developed following the local application of benzopyrene to castrated mice (Gardner, unpublished) . The epithelium of the vagina of castrated mice thus appears to respond in much the same way as does the skin to this carcinogenic chemical, but unlike the skin, it also responds to estrogens or estrogen-androgen treatment.
Mice of certain strains did not tolerate treatment with estrogens as well as others. The factors causing death in some animals were not determined. In some other animals known factors not relating to the treatment are involved. Pyometra, hydronephrosis, renal infections, hemorrhage, and other factors being studied are responsible for the death of many of these animals and apparently associated with the treatment involved.
Lesions of a malignant nature were wholly lacking in the uterine horns, as has been previously emphasized. One of six mice (four from the N strain and two from the C3H strain) developed a large invasive epithelial lesion of the cervix following the injection of estrogen and progesterone.
The general responses of the uteri, cervices, and vaginas of the mice given estrogens and androgens are described. The tendency for uterine epithelial metaplasia was highest in mice in which the injections were started during the first week of life or in older animals which developed pyometra. Pyometra developed most frequently in mice from the N, C57, and F strains, but was not entirely limited to any one strain.
Degenerative changes, hyalin and fibrous, appeared in the uterine stroma and occasionally in the cervix. The uterine, cervical, and vaginal epithelium was infrequently found to be in a hyperplastic state. Table 9 . This lesion involved the entire cervix and upper vagina. X 100.
FIG. 20. A portion of a large epithelial lesion (stage 4) showing the extent of penetration of the vaginal wall and a section of the rectum. This lesion developed in GH-strain mouse 7, Table 9 . X 100.
FIG. 21.
Another section of the carcinoma in the same mouse described in Fig. 20 . X 100.
